Pharmaceuticals Top 5 Emerging Markets Industry Guide 2019-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $995	322 Pages	MarketLine	September, 2024	MTLN19325944

Best Price Guarantee
Price	from $995
Length	322 Pages
Publisher	MarketLine
Published Date	September, 2024
SKU	MTLN19325944

Pharmaceuticals Top 5 Emerging Markets Industry Guide 2019-2028

Summary

The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

These countries contributed $262.3 billion to the global pharmaceuticals industry in 2023, with a compound annual growth rate (CAGR) of 6.4% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $337.0 billion in 2028, with a CAGR of 5.1% over the 2023-28 period.
Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $161.0 billion in 2023. This was followed by India and Brazil with a value of $48.0 and $30.7 billion, respectively.
China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $217.4 billion in 2028, followed by India and Brazil with expected values of $56.0 and $34.9 billion, respectively.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country

Reasons to Buy

What was the size of the emerging five pharmaceuticals market by value in 2023?
What will be the size of the emerging five pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in the emerging five pharmaceuticals market?

1 Introduction: 1.1. What is this report about?; 1.2. Who is the target reader?; 1.3. How to use this report; 1.4. Definitions
2 Top 5 Emerging Countries Pharmaceuticals: 2.1. Industry Outlook
3 Pharmaceuticals in South Africa: 3.1. Market Overview; 3.2. Market Data; 3.3. Market Segmentation; 3.4. Market outlook; 3.5. Five forces analysis
4 Macroeconomic Indicators: 4.1. Country data
5 Pharmaceuticals in Brazil: 5.1. Market Overview; 5.2. Market Data; 5.3. Market Segmentation; 5.4. Market outlook; 5.5. Five forces analysis
6 Macroeconomic Indicators: 6.1. Country data
7 Pharmaceuticals in China: 7.1. Market Overview; 7.2. Market Data; 7.3. Market Segmentation; 7.4. Market outlook; 7.5. Five forces analysis
8 Macroeconomic Indicators: 8.1. Country data
9 Pharmaceuticals in India: 9.1. Market Overview; 9.2. Market Data; 9.3. Market Segmentation; 9.4. Market outlook; 9.5. Five forces analysis
10 Macroeconomic Indicators: 10.1. Country data
11 Pharmaceuticals in Mexico: 11.1. Market Overview; 11.2. Market Data; 11.3. Market Segmentation; 11.4. Market outlook; 11.5. Five forces analysis
12 Macroeconomic Indicators: 12.1. Country data
13 Company Profiles: 13.1. BASF SE; 13.2. Sinopharm Group Co Ltd; 13.3. F. Hoffmann-La Roche Ltd; 13.4. The Procter & Gamble Co; 13.5. Shanghai Pharmaceuticals Holding Co Ltd; 13.6. CSPC Pharmaceutical Group Ltd; 13.7. Takeda Pharmaceutical Co Ltd; 13.8. Novartis AG; 13.9. GSK plc; 13.10. AstraZeneca Plc; 13.11. Sanofi; 13.12. Roche Holding AG; 13.13. Laboratoires Pierre Fabre SA; 13.14. Ipsen SA; 13.15. Les Laboratoires Servier SAS; 13.16. Bayer AG; 13.17. Boehringer Ingelheim GmbH; 13.18. CSL Ltd; 13.19. Astrazeneca Pty Ltd; 13.20. Mayne Pharma Group Ltd; 13.21. Hypera SA; 13.22. Ache Laboratorios Farmaceuticos SA; 13.23. EMS Sigma Pharma; 13.24. Eurofarma Laboratorios SA; 13.25. Johnson & Johnson; 13.26. Sanofi-Aventis Canada Inc; 13.27. Apotex Inc; 13.28. Bausch Health Companies Inc; 13.29. Jiangsu Hengrui Medicine Co Ltd; 13.30. Lupin Ltd; 13.31. Cipla Ltd; 13.32. Dr. Reddy's Laboratories Ltd; 13.33. PT Kalbe Farma Tbk; 13.34. PT Kimia Farma Tbk; 13.35. PT Tempo Scan Pacific Tbk; 13.36. Pfizer Italia Srl; 13.37. A. Menarini Industrie Farmaceutiche Riunite Srl; 13.38. Chiesi Farmaceutici SpA; 13.39. Recordati SpA; 13.40. Daiichi Sankyo Co Ltd; 13.41. Astellas Pharma Inc; 13.42. Otsuka Holdings Co Ltd; 13.43. Sanofi-Aventis de Mexico SA de CV; 13.44. Genomma Lab Internacional SAB de CV; 13.45. Bayer de Mexico SA de CV; 13.46. Boehringer Ingelheim Mexico; 13.47. Pfizer BV; 13.48. Astellas Pharma Europe Ltd; 13.49. Merck & Co Inc; 13.50. AbbVie Inc; 13.51. Pfizer Inc; 13.52. Bristol-Myers Squibb Co; 13.53. OTC Pharma International BV; 13.54. Pharmstandard; 13.55. Binnopharm Group; 13.56. Novo Nordisk AS; 13.57. H. Lundbeck AS; 13.58. Pfizer Laboratories (Pty) Ltd; 13.59. Aspen Pharmacare Holdings Ltd; 13.60. Adcock Ingram Holdings Ltd; 13.61. Chong Kun Dang Pharmaceutical Corp.; 13.62. Yuhan Corp; 13.63. Celltrion Inc; 13.64. Hanmi Pharmaceuticals Co Ltd; 13.65. Grifols SA; 13.66. Almirall SA; 13.67. Laboratorios Farmaceuticos Rovi SA; 13.68. Abdi Ibrahim Ilac Sanayi ve Ticaret AS; 13.69. Deva Holding AS
14 Appendix: 14.1. Methodology; 14.2. About MarketLine
List of Tables: Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2019-28; Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2019-23; Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2023-28; Table 4: South Africa pharmaceuticals market value: $ billion, 2018-23; Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2023; Table 6: South Africa pharmaceuticals market value forecast: $ billion, 2023-28; Table 7: South Africa Size of Population (million), 2019-23; Table 8: South Africa real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 9: South Africa GDP (Current Prices, $ Billion), 2019-23; Table 10: South Africa Inflation, 2019-23; Table 11: South Africa Consumer Price Index (Absolute), 2019-23; Table 12: South Africa exchange rate, 2018-23; Table 13: Brazil pharmaceuticals market value: $ billion, 2018-23; Table 14: Brazil pharmaceuticals market geography segmentation: $ billion, 2023; Table 15: Brazil pharmaceuticals market value forecast: $ billion, 2023-28; Table 16: Brazil Size of Population (million), 2019-23; Table 17: Brazil real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 18: Brazil GDP (Current Prices, $ Billion), 2019-23; Table 19: Brazil Inflation, 2019-23; Table 20: Brazil Consumer Price Index (Absolute), 2019-23; Table 21: Brazil exchange rate, 2018-23; Table 22: China pharmaceuticals market value: $ billion, 2018-23; Table 23: China pharmaceuticals market geography segmentation: $ billion, 2023; Table 24: China pharmaceuticals market value forecast: $ billion, 2023-28; Table 25: China Size of Population (million), 2019-23; Table 26: China real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 27: China GDP (Current Prices, $ Billion), 2019-23; Table 28: China Inflation, 2019-23; Table 29: China Consumer Price Index (Absolute), 2019-23; Table 30: China exchange rate, 2018-23; Table 31: India pharmaceuticals market value: $ billion, 2018-23; Table 32: India pharmaceuticals market geography segmentation: $ billion, 2023; Table 33: India pharmaceuticals market value forecast: $ billion, 2023-28; Table 34: India Size of Population (million), 2019-23; Table 35: India real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 36: India GDP (Current Prices, $ Billion), 2019-23; Table 37: India Inflation, 2019-23; Table 38: India Consumer Price Index (Absolute), 2019-23; Table 39: India exchange rate, 2018-23; Table 40: Mexico pharmaceuticals market value: $ billion, 2018-23; Table 41: Mexico pharmaceuticals market geography segmentation: $ billion, 2023; Table 42: Mexico pharmaceuticals market value forecast: $ billion, 2023-28; Table 43: Mexico Size of Population (million), 2019-23; Table 44: Mexico real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 45: Mexico GDP (Current Prices, $ Billion), 2019-23; Table 46: Mexico Inflation, 2019-23; Table 47: Mexico Consumer Price Index (Absolute), 2019-23; Table 48: Mexico exchange rate, 2018-23; Table 49: BASF SE: key facts; Table 50: BASF SE: Annual Financial Ratios; Table 51: BASF SE: Key Employees; Table 52: Sinopharm Group Co Ltd: key facts; Table 53: Sinopharm Group Co Ltd: Annual Financial Ratios; Table 54: Sinopharm Group Co Ltd: Key Employees; Table 55: F. Hoffmann-La Roche Ltd: key facts; Table 56: F. Hoffmann-La Roche Ltd: Key Employees; Table 57: The Procter & Gamble Co: key facts; Table 58: The Procter & Gamble Co: Annual Financial Ratios; Table 59: The Procter & Gamble Co: Key Employees; Table 60: The Procter & Gamble Co: Key Employees Continued; Table 61: Shanghai Pharmaceuticals Holding Co Ltd: key facts; Table 62: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios; Table 63: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees; Table 64: CSPC Pharmaceutical Group Ltd: key facts; Table 65: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios; Table 66: CSPC Pharmaceutical Group Ltd: Key Employees; Table 67: Takeda Pharmaceutical Co Ltd: key facts; Table 68: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios; Table 69: Takeda Pharmaceutical Co Ltd: Key Employees; Table 70: Takeda Pharmaceutical Co Ltd: Key Employees Continued; Table 71: Novartis AG: key facts; Table 72: Novartis AG: Annual Financial Ratios; Table 73: Novartis AG: Key Employees; Table 74: GSK plc: key facts; Table 75: GSK plc: Annual Financial Ratios; Table 76: GSK plc: Key Employees; Table 77: AstraZeneca Plc: key facts; Table 78: AstraZeneca Plc: Annual Financial Ratios; Table 79: AstraZeneca Plc: Key Employees; Table 80: Sanofi: key facts; Table 81: Sanofi: Annual Financial Ratios; Table 82: Sanofi: Key Employees; Table 83: Sanofi: Key Employees Continued; Table 84: Roche Holding AG: key facts; Table 85: Roche Holding AG: Annual Financial Ratios; Table 86: Roche Holding AG: Key Employees; Table 87: Laboratoires Pierre Fabre SA: key facts; Table 88: Laboratoires Pierre Fabre SA: Key Employees; Table 89: Ipsen SA: key facts; Table 90: Ipsen SA: Annual Financial Ratios; Table 91: Ipsen SA: Key Employees
List of Figures: Figure 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2019-28; Figure 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2019-23; Figure 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2023-28; Figure 4: South Africa pharmaceuticals market value: $ billion, 2018-23; Figure 5: South Africa pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 6: South Africa pharmaceuticals market value forecast: $ billion, 2023-28; Figure 7: Forces driving competition in the pharmaceuticals market in South Africa, 2023; Figure 8: Drivers of buyer power in the pharmaceuticals market in South Africa, 2023; Figure 9: Drivers of supplier power in the pharmaceuticals market in South Africa, 2023; Figure 10: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2023; Figure 11: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2023; Figure 12: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2023; Figure 13: Brazil pharmaceuticals market value: $ billion, 2018-23; Figure 14: Brazil pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 15: Brazil pharmaceuticals market value forecast: $ billion, 2023-28; Figure 16: Forces driving competition in the pharmaceuticals market in Brazil, 2023; Figure 17: Drivers of buyer power in the pharmaceuticals market in Brazil, 2023; Figure 18: Drivers of supplier power in the pharmaceuticals market in Brazil, 2023; Figure 19: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2023; Figure 20: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2023; Figure 21: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2023; Figure 22: China pharmaceuticals market value: $ billion, 2018-23; Figure 23: China pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 24: China pharmaceuticals market value forecast: $ billion, 2023-28; Figure 25: Forces driving competition in the pharmaceuticals market in China, 2023; Figure 26: Drivers of buyer power in the pharmaceuticals market in China, 2023; Figure 27: Drivers of supplier power in the pharmaceuticals market in China, 2023; Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2023; Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2023; Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in China, 2023; Figure 31: India pharmaceuticals market value: $ billion, 2018-23; Figure 32: India pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 33: India pharmaceuticals market value forecast: $ billion, 2023-28; Figure 34: Forces driving competition in the pharmaceuticals market in India, 2023; Figure 35: Drivers of buyer power in the pharmaceuticals market in India, 2023; Figure 36: Drivers of supplier power in the pharmaceuticals market in India, 2023; Figure 37: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2023; Figure 38: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2023; Figure 39: Drivers of degree of rivalry in the pharmaceuticals market in India, 2023; Figure 40: Mexico pharmaceuticals market value: $ billion, 2018-23; Figure 41: Mexico pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 42: Mexico pharmaceuticals market value forecast: $ billion, 2023-28; Figure 43: Forces driving competition in the pharmaceuticals market in Mexico, 2023; Figure 44: Drivers of buyer power in the pharmaceuticals market in Mexico, 2023; Figure 45: Drivers of supplier power in the pharmaceuticals market in Mexico, 2023; Figure 46: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2023; Figure 47: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2023; Figure 48: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2023